Ground Truth Labs
Improving outcomes for every cancer patient with AI driven insights from digital pathology1-10 EmployeesActively Hiring
- Responds within three weeksBased on past data, Ground Truth Labs usually responds to incoming applications within three weeks
- Early StageStartup in initial stages
- Recently fundedRaised funding in the past six months
Ground Truth Labs careers
Ground Truth Labs uses machine learning and computer vision to unlock insights from tissue and multi-modal data. Our mission is to improve outcomes for every cancer patient with AI driven insights from digital pathology.
We're a lively, fast-paced, and cooperative team. If you're keen on joining us in our mission to use AI to alleviate the global impact of cancer, we'd be delighted to hear from you. Explore opportunities here on Wellfound and at groundtruthlabs.com/careers
---
Tissue morphology contains an enormous amount of signal that is not captured by today's methods. We see the biggest opportunity in histology and have developed a platform to support biotech and pharmaceutical partners in their therapy development through a richer, more insightful understanding of underlying biology and the effects of their therapies on patients.
Our interdisciplinary team has an extensive track record in machine learning, medical image analysis, pathology, clinical oncology, medical devices, and biopharma services. We deploy our platform in a number of development projects with pharma and have established collaborations with leading academic centers in the UK, Europe, and the United States.
We're a lively, fast-paced, and cooperative team. If you're keen on joining us in our mission to use AI to alleviate the global impact of cancer, we'd be delighted to hear from you. Explore opportunities here on Wellfound and at groundtruthlabs.com/careers
---
Tissue morphology contains an enormous amount of signal that is not captured by today's methods. We see the biggest opportunity in histology and have developed a platform to support biotech and pharmaceutical partners in their therapy development through a richer, more insightful understanding of underlying biology and the effects of their therapies on patients.
Our interdisciplinary team has an extensive track record in machine learning, medical image analysis, pathology, clinical oncology, medical devices, and biopharma services. We deploy our platform in a number of development projects with pharma and have established collaborations with leading academic centers in the UK, Europe, and the United States.
Founders Associate
London
4 days ago
Alan Aberdeen
Valuation
$0
Funded over
2 rounds
Latest round
Seed (Mar 2026)
